{"url_path":"/sec/aaql/10-k/2026/item-8","section_key":"item-8","section_title":"Item 8 Financial Statements and Supplementary Data**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1672571/0001493152-26-033212-index.html","accession_number":"0001493152-26-033212","cik":"0001672571","ticker":"AAQL","issuer_name":"Antiaging Quantum Living Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672571/0001493152-26-033212-index.html","primary_entity_key":"0001672571","primary_entity_name":"Antiaging Quantum Living Inc."},"word_count":10560,"has_tables":true,"body_markdown":"**Item\n8. Financial Statements and Supplementary Data**\n\n \n\nOur\naudited financial statements are set forth in this Annual Report beginning on page F-2.\n\n \n\n12\n\n \n\n \n\n**ANTIAGING\nQUANTUM LIVING INC.**\n\n**INDEX\nTO FINANCIAL STATEMENTS**\n\n \n\n[Report of Independent Registered Public Accounting Firm](#am_001) (PCAOB ID NO: 6743)\n \nF-2\n\n \n \n \n\n[Consolidated Balance Sheets As of March 31, 2026 and 2025](#fn_001)\n\n \nF-3\n\n** **\n \n \n\n[Consolidated Statements of Operations and Comprehensive Income For the years ended March 31, 2026 and 2025](#fn_002)\n\n \nF-4\n\n** **\n \n \n\n[Consolidated Statements of Changes in Shareholders’ Deficit For the years ended March 31, 2026 and 2025](#fn_003)\n\n \nF-5\n\n** **\n \n \n\n[Consolidated Statements of Cash Flows For the years ended March 31, 2026 and 2025](#fn_004)\n\n \nF-6\n\n** **\n \n \n\n[Notes to Financial Statements](#fn_005)\n\n \nF-7\n\n \n\nF-1\n\n \n\n \n\n \n\n**J&S\nASSOCIATE PLT**\n\n202206000037\n(LLP0033395-LCA) & AF002380\n\n(Registered\nwith PCAOB and MIA)\n\nB-11-14,\nMegan Avenue II\n\n12,Jalan\nYap Kwan Seng, 50450, Kuala Lumpur, Malaysia\n\n \nTel:\n+603-4813 9469\n\nEmail : info@jns-associate.com\n\nWebsite : jns-associate.com\n\n \n\n**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**\n\n \n\nThe\nBoard of Directors and Shareholders of\n\n**Antiaging\nQuantum Living Inc.**\n\n \n\n**Opinion\non the Financial Statement**\n\n \n\nWe\nhave audited the accompanying consolidated balance sheets of Antiaging Quantum Living Inc. and its subsidiary (collectively the ‘Company’)\nas of March 31, 2026 and 2025, and the related consolidated statements of income and comprehensive income, consolidated statements of\nchanges in shareholders’ equity, and consolidated statements of cash flows for the years ended March 31, 2026 and 2025, and the\nrelated notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present\nfairly, in all material respects, the financial position of the Company as of March 31, 2026 and 2025, and the results of its operations\nand its cash flows for the years ended March 31, 2026 and 2025, in conformity with accounting principles generally accepted in the United\nStates of America.\n\n \n\n**Basis\nfor Opinion**\n\n \n\nThese\nfinancial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s\nfinancial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board\n(United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal\nsecurities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.\n\n \n\nWe\nconducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain\nreasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company\nis not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit,\nwe are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion\non the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.\n\n \n\nOur\naudit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or\nfraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding\nthe amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant\nestimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides\na reasonable basis for our opinion.\n\n \n\n**Substantial\nDoubt about the Company’s Ability to Continue as a Going Concern**\n\n \n\nThe\naccompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed\nin Note 3 to the financial statements, the Company has suffered recurring losses from operations and has a net capital deficiency that\nraise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also\ndescribed in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.\n\n \n\n*/s/J&S\nAssociate PLT*\n \n\nCertified Public Accountants\n \n\nPCAOB No: 6743\n \n\n \n\nWe\nhave served as the Company’s auditor since 2025.\n\n \n\nKuala\nLumpur, Malaysia\n\nJuly\n14, 2026\n\n \n\nF-2\n\n \n\n \n\n**ANTIAGING\nQUANTUM LIVING INC.**\n\n**Consolidated\nBalance Sheets**\n\n**As\nof March 31, 2026 and 2025**\n\n \n\n  \nMarch 31,  \nMarch 31, \n\n  \n2026  \n2025 \n\nASSETS \n    \n   \n\nCurrent Assets \n    \n   \n\nCash and cash equivalents \n$503,486  \n$370,549 \n\nAccounts receivable, net \n 30,000  \n 85,788 \n\nInventories, net \n 219,036  \n - \n\nAdvances to suppliers \n 231,523  \n 132,123 \n\nOther receivables and current assets \n 229,937  \n 222,055 \n\nTotal Current Assets \n 1,213,982  \n 810,515 \n\nNon-Current Assets \n    \n   \n\nProperty and equipment, net \n 148,215  \n 120,769 \n\nIntangible assets, net \n 12,806  \n 13,551 \n\nOperating lease right of use asset, net \n 347,682  \n 644,515 \n\nTotal Non-Current Assets \n 508,703  \n 778,835 \n\nTotal Assets \n 1,722,685  \n 1,589,350 \n\n  \n    \n   \n\nLIABILITIES AND SHAREHOLDERS’ EQUITY \n    \n   \n\nCurrent Liabilities \n    \n   \n\nAccounts payable and accrued expenses \n 389,582  \n 50,244 \n\nOther payables \n 153,364  \n 49,097 \n\nDue to related parties \n 980,000  \n 520,000 \n\nTaxes payable \n 1,297  \n 3,960 \n\nContract liabilities \n 97,605  \n 8,475 \n\nOperating lease liabilities - current portion \n 51,172  \n 46,050 \n\nTotal Current Liabilities \n 1,673,020  \n 677,826 \n\nNon-Current Liabilities \n    \n   \n\nOperating lease liabilities - non-current \n 319,621  \n 366,740 \n\nLong term notes and loans payable-related party \n -  \n 1,674,801 \n\nLong term loans payable \n 405,915  \n - \n\nTotal Non-Current Liabilities \n 725,536  \n 2,041,541 \n\nTotal Liabilities \n 2,398,556  \n 2,719,367 \n\n  \n    \n   \n\nCommitments and Contingencies \n    \n - \n\n  \n    \n   \n\nShareholders’ Equity \n    \n   \n\nClass A Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; 34,275,340 and 29,995,000 shares issued and outstanding at March 31, 2026 and 2025 \n 30,423  \n 29,995 \n\nClass B Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; no shares issued and outstanding at March 31, 2026 and 2025 \n -  \n - \n\nClass C Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; no shares issued and outstanding at March 31, 2026 and 2025 \n -  \n - \n\nClass D Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; no shares issued and outstanding at March 31, 2026 and 2025 \n -  \n - \n\nClass E Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; no shares issued and outstanding at March 31, 2026 and 2025 \n -  \n - \n\nCommon stock, value \n -  \n - \n\nAdditional paid-in capital \n 1,527,204  \n 243,530 \n\nAccumulated deficit \n (2,247,358) \n (1,409,712)\n\nAccumulated other comprehensive (loss) income \n 13,860  \n 6,170 \n\nTotal Shareholders’ Deficit \n (675,871) \n (1,130,017)\n\nTotal Liabilities and Shareholders’ Deficit \n$1,722,685  \n$1,589,350 \n\n* *\n\n*The\naccompanying notes are an integral part of these consolidated financial statements.*\n\n \n\nF-3\n\n \n\n \n\n**ANTIAGING\nQUANTUM LIVING INC.**\n\n**Consolidated\nStatements of Operations and Comprehensive Income**\n\n**For\nthe years ended March 31, 2026 and 2025**\n\n \n\n  \n   \n  \n\n  \nYears ended \n\n  \nMarch 31,  \nMarch 31, \n\n  \n2026  \n2025 \n\nRevenues, net \n$1,034,385  \n$817,898 \n\nCost of revenues \n 332,262  \n 389,381 \n\nGross profit \n 702,123  \n 428,517 \n\n  \n    \n   \n\nOperating expenses: \n    \n   \n\nSelling and marketing expenses \n 160,731  \n 158,136 \n\nGeneral and administrative expenses \n 1,376,793  \n 1,060,340 \n\nTotal operating expenses \n 1,537,524  \n 1,218,476 \n\n  \n    \n   \n\nLoss from operations \n (835,401) \n (789,959)\n\n  \n    \n   \n\nOther income: \n    \n   \n\nInterest income \n 163  \n 79 \n\nOther income \n 14,252  \n 69,471 \n\nTotal other income \n 14,415  \n 69,550 \n\n  \n    \n   \n\nLoss before income tax \n (820,986) \n (720,409)\n\n  \n    \n   \n\nIncome tax expense \n 16,660  \n - \n\nNet loss \n$(837,646) \n$(720,409)\n\n  \n    \n   \n\nWeighted average shares outstanding \n    \n   \n\nBasic and diluted \n 31,484,324  \n 29,995,000 \n\n  \n    \n   \n\nLoss per share \n    \n   \n\nBasic and diluted \n$(0.0266) \n$(0.0240)\n\n  \n    \n   \n\nComprehensive loss: \n    \n   \n\nNet loss \n$(837,646) \n$(720,409)\n\nOther comprehensive loss: \n    \n   \n\nForeign currency translation adjustment \n 7,690  \n 3,562 \n\nTotal comprehensive loss \n$(829,956) \n$(716,847)\n\n* *\n\n*The\naccompanying notes are an integral part of these consolidated financial statements.*\n\n \n\nF-4\n\n \n\n \n\n**ANTIAGING\nQUANTUM LIVING INC.**\n\n**Consolidated\nStatements of Changes in Shareholders’ Deficit**\n\n**For\nthe years ended March 31, 2026 and 2025**\n\n \n\n \n \n\n**Number of**\n\n**Shares**\n  \nAmount  \n\n****\n\n**Paid-in Capital**\n  \nAccumulated Deficit  \n\n****\n\n****\n\n**Comprehensive**\n\n**Income/(Loss)**\n  \nTotal \n\n  \n\n**Class A**\n\n**Common stock**\n  \nAdditional  \n   \n\n**Accumulated**\n\n**other**\n  \n  \n\n  \n\n**Number of**\n\n**Shares**\n  \nAmount  \n\nPaid-in\n\nCapital\n  \nAccumulated Deficit  \n\n**Comprehensive**\n\n**Income (Loss)**\n  \nTotal \n\n  \n   \n   \n   \n   \n   \n  \n\nBalance at March 31, 2025 \n 29,995,000  \n$29,995  \n$243,530  \n$(1,409,712) \n$6,170  \n$(1,130,017)\n\nConversion of notes payable to common stock \n 4,280,340  \n 428  \n 1,283,674  \n -  \n -  \n 1,284,102 \n\nNet loss \n -  \n -  \n -  \n (837,646) \n -  \n (837,646)\n\nForeign currency translation adjustment \n -  \n -  \n -  \n -  \n 7,690  \n 7,690 \n\nBalance at March 31, 2026 \n 34,275,340  \n$30,423  \n$1,527,204  \n$(2,247,358) \n$13,860  \n$(675,871)\n\n  \n    \n    \n    \n    \n    \n   \n\nBalance at March 31, 2024 \n 29,995,000  \n$29,995  \n$243,530  \n$(689,303) \n$2,608  \n$(413,170)\n\nBalance  \n 29,995,000  \n$29,995  \n$243,530  \n$(689,303) \n$2,608  \n$(413,170)\n\nNet loss \n -  \n -  \n -  \n (720,409) \n -  \n (720,409)\n\nForeign currency translation adjustment \n -  \n -  \n -  \n -  \n 3,562  \n 3,562 \n\nBalance at March 31, 2025 \n 29,995,000  \n$29,995  \n$243,530  \n$(1,409,712) \n$6,170  \n$(1,130,017)\n\nBalance  \n 29,995,000  \n$29,995  \n$243,530  \n$(1,409,712) \n$6,170  \n$(1,130,017)\n\n \n\n*The\naccompanying notes are an integral part of these consolidated financial statements.*\n\n \n\nF-5\n\n \n\n \n\n**ANTIAGING\nQUANTUM LIVING INC.**\n\n**Consolidated\nStatements of Cash Flows**\n\n**For\nthe years ended March 31, 2026 and 2025**\n\n** **\n\n  \n2026  \n2025 \n\n  \nYears ended \n\n  \nMarch 31,  \nMarch 31, \n\n  \n2026  \n2025 \n\nOperating activities \n    \n   \n\nNet loss \n$(837,646) \n$(720,409)\n\nAdjustments to reconcile net loss to net cash used in operating activities \n    \n   \n\nDepreciation and amortization expense \n 134,792  \n 144,271 \n\nAmortization of operating lease ROU assets \n 332,320  \n 330,671 \n\nWrite-off assets \n -  \n 27,000 \n\nImpairment loss on property and equipment \n 4,007  \n - \n\nChanges in assets and liabilities \n    \n   \n\nDecrease (increase) in accounts receivable \n 57,657  \n (84,267)\n\nIncrease in inventories \n (216,624) \n - \n\nIncrease in advances to suppliers \n (92,753) \n (132,123)\n\nDecrease (increase) in prepaid expenses \n 15,061  \n (65,489)\n\nIncrease in other receivables and current assets \n (14,595) \n (96,097)\n\nIncrease (decrease) in accounts payable and accrued expenses \n 317,479  \n (4,428)\n\nIncrease in other payables \n 112,507  \n 34,850 \n\nIncrease in contract liabilities \n 89,130  \n 4,130 \n\nDecrease in operating lease liabilities \n (72,360) \n (338,389)\n\nNet cash used in operating activities \n (171,025) \n (900,280)\n\n  \n    \n   \n\nInvesting activities \n    \n   \n\nPurchase of fixed assets \n (162,434) \n (49,488)\n\nPurchase of intangible assets \n -  \n (13,857)\n\nNet cash used in investing activities \n (162,434) \n (63,345)\n\n  \n    \n   \n\nFinancing activities \n    \n   \n\nProceeds from notes payables \n -  \n 803,734 \n\nProceeds from related party payables \n 460,000  \n 364,303 \n\nNet cash provided by financing activities \n 460,000  \n 1,168,037 \n\n  \n    \n   \n\nNet increase of cash and cash equivalents \n 126,541  \n 204,412 \n\nEffect of foreign currency translation on cash and cash equivalents \n 6,396  \n (415)\n\nCash and cash equivalents – beginning \n 370,549  \n 166,552 \n\nCash and cash equivalents – ending \n$503,486  \n$370,549 \n\n  \n    \n   \n\nSupplementary cash flow information: \n    \n   \n\nInterest paid \n$-  \n$- \n\nIncome taxes paid \n$16,660  \n$- \n\n  \n    \n   \n\nNon-cash financing and investing activities: \n    \n   \n\nRecognized ROU assets through lease liabilities \n$-  \n$424,790 \n\nConversion of loan payable to promissory note payable \n$-  \n$1,284,103 \n\nDebt assignment to related party \n$-  \n$1,216,440 \n\nConversion of notes payable to common stock \n$1,284,102  \n$- \n\n \n\n*The\naccompanying notes are an integral part of these consolidated financial statements.*\n\n \n\nF-6\n\n \n\n \n\n**ANTIAGING\nQUANTUM LIVING INC**\n\n**NOTES\nTO FINANCIAL STATEMENTS**\n\n \n\n**NOTE\n1 – ORGANIZATION AND PRINCIPAL ACTIVITIES**\n\n \n\nAntiaging\nQuantum Living Inc. (the “Company”, “us”, “we” or “our”) was incorporated under the laws\nof the State of New York on December 29, 2014.\n\n \n\nOn\nJuly 1, 2019, Lansdale Inc, the principal stockholder of the Company (“Seller”) an entity controlled by the Company’s\nformer President, Mr. Wanjun Xie, entered into a Stock Purchase Agreement (the “Agreement”) with Dazhong 368 Inc, (the “Buyer”),\npursuant to which, a total of 9,000,000 shares of Class A common stock of the Company were transferred to the Buyer, representing approximately\n90% of the Company’s issued and outstanding shares of Class A common stock, resulting in a change of the control of the Company.\nMr. Dingshan Zhang was appointed as the President and CEO of the Company at the same date.\n\n \n\nOn\nApril 10, 2023, Mr. Barry Wan acquired control of 29,215,000 restricted shares of common stock (the “Purchased Shares”) of\nthe Company, representing approximately 97% of the Company’s total issued and outstanding common stock (the “Common Stock”)\nfrom Dazhong 368 Inc and Sophia 33 Inc, two New York corporations controlled by the Company’s then President, Chief Executive Officer\nand sole director, Dingshan Zhang (the former President) pursuant to the terms of a Stock Purchase Agreement by and among the parties\nthereto (the “Stock Purchase Agreement”). Pursuant to the Stock Purchase Agreement (“SPA”), Mr. Wan paid an aggregate\npurchase price of four hundred thousand dollars ($400,000.00) to Mr. Zhang in exchange for the Purchased Shares. The foregoing transaction\nresulted in a change of control of the Company, with Mr. Wan acquiring 97% of the Company’s outstanding Common Stock held through\nNew Lite Ventures LLC, a New York LLC. Both before and after the transactions, the Company had 29,995,000 shares of its common stock\noutstanding.\n\n \n\nIn\nconnection with the transaction, on April 10, 2023, Mr. Dingshan Zhang resigned from all positions he held with the Company. On April\n10, 2023, Ms. Jing Wan was appointed by our majority shareholder as our Chief Executive Officer, Chief Financial Officer, President and\nDirector. On June 16, 2023, Mr. Barry Wan consented to act as the new CEO and CFO after Ms. Jing Wan resigned. The Company was renamed\nas Antiaging Quantum Living Inc on June 14, 2023 by the new management. The Company is an investment holding company; its primary business\noperations are conducted through its subsidiaries as described below.\n\n \n\nAAQL\nInc. (“BVI Holding”) was incorporated under the Laws of the British Virgin Islands to function as a holding company responsible\nfor managing all business operations outside of the United States.\n\n \n\nAAQL\nHK Limited (“Hong Kong Holding”) was incorporated under the Laws of Hong Kong as a wholly-owned subsidiary of the BVI Holding.\nHong Kong Holding’s primary role is to act as a holding company overseeing business activities exclusively within the Asia-Pacific\nmarkets.\n\n \n\nAntiaging\nDoctor Hangzhou Holding LTD (“Dao Ling Doctor Hangzhou”) was incorporated as a wholly-owned subsidiary of Hong Kong Holding\non November 13, 2023 under the laws of the People’s Republic of China, with its principal place of business situated in Xiaoshan\nDistrict, Hangzhou, Zhejiang Province.\n\n \n\nDao\nLing Doctor (Zhejiang) Health Management Limited (“Dao Ling Doctor Zhejiang”) was incorporated as a wholly-owned subsidiary\nof Dao Ling Doctor Hangzhou on November 30, 2023 under the laws of the People’s Republic of China, with its principal place of\nbusiness situated in Hangzhou, Zhejiang Province.\n\n \n\nDao\nLing Doctor (Huzhou) Health Management Limited (“Dao Ling Doctor Huzhou”) was incorporated as a wholly-owned subsidiary of\nDao Ling Doctor Hangzhou on December 6, 2023 under the laws of the People’s Republic of China, with its principal place of business\nsituated in Huzhou, Zhejiang Province.\n\n \n\nAnti-Aging\nCare LLC (“Anti-Aging Care”) was incorporated as a wholly-owned subsidiary of Antiaging Quantum Living Inc. on October 21,\n2024 under the laws of New York.\n\n \n\nThe\nsubsidiaries’ business includes e-commerce platform development and management, personalized marketing strategies, and brand licensing.\nIt also provides technical support and maintenance for distributors, along with health consulting (excluding diagnosis and treatment),\nnetwork security software development, and big data services. Through these integrated offerings, the group enhances the market presence\nand operational efficiency of the ‘Dao Ling Doctor’ brand.”\n\n \n\nAntiaging\nQuantum Living Inc. and its subsidiaries are collectively referred to as the “Company”.\n\n \n\nF-7\n\n \n\n \n\n**NOTE\n2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**\n\n \n\nBasis\nof Presentation and Principles of Consolidation\n\n \n\nThe\naccompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the\nUnited States of America (“U.S. GAAP”), and include the assets, liabilities, revenues, expenses and cash flows of all subsidiaries.\nAll significant inter-company transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.\n\n \n\nUse\nof Estimates\n\n \n\nThe\naccompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”)\nand the rules and regulations of the Securities and Exchange Commission (the “SEC”).\n\n \n\nThe\npreparation of the Company’s financial statements in conformity with GAAP requires management to make estimates, judgments and\nassumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those\nestimates and assumptions.\n\n \n\nSignificant estimates and assumptions made by management\ninclude, but are not limited to, the recognition of revenue (including the portfolio approach used for estimating the proportional performance\nand breakage of multi-session service packages), the allowance for expected credit losses, the valuation of lease right-of-use assets\nand lease liabilities, and the valuation allowance for deferred tax assets.\n\n \n\nFunctional\nand presentation currency\n\n \n\nThe\nfunctional currency of the Company is the currency of the primary economic environment in which the Company operates which is Chinese\nYuan (“RMB”). The RMB is not freely convertible into the US dollar and may be subject to PRC currency restrictions for payments,\nincluding the distributions of dividends or retained earnings to the Company by its subsidiaries or its variable interest entities.\n\n \n\nTransactions\nin currencies other than the entity’s functional currency are recorded at the rates of exchange prevailing on the date of the transaction.\nAt the end of each reporting period, monetary items denominated in foreign currencies are translated at the rates prevailing at the end\nof the reporting periods. Exchange differences arising on the settlement of monetary items and on translation of monetary items at period-end\nare included in income statement of the period.\n\n \n\nFor\nthe purpose of presenting these financial statements, the Company’s assets and liabilities are expressed in US$ at the exchange\nrate on the balance sheet date, stockholder’s equity accounts are translated at historical rates, and income and expense items\nare translated at the weighted average exchange rate during the period. The resulting translation adjustments are reported under accumulated\nother comprehensive income (loss) in the stockholder’s equity (deficits) section of the balance sheets.\n\n \n\nExchange\nrate used for the translation as follows:\n\n SCHEDULE OF EXCHANGE RATE \n\nUS$ to RMB \nPeriod End  \nAverage \n\nMarch 31, 2026 \n 6.8980  \n 7.1019 \n\nMarch 31, 2025 \n 7.2567  \n 7.2163 \n\n \n\nCash\nand Cash Equivalents\n\n \n\nCash\nand cash equivalents include cash in banks, bank deposits, and highly liquid investments with maturities of three months or less at the\ndate of origination.\n\n \n\nAccounts\nreceivable, net\n\n \n\nThe\nCompany records accounts receivable at net realizable value consisting of the carrying amount less an allowance for uncollectible accounts.\nThe allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s\nexisting accounts receivable. The Company determines the allowance based on aging data, historical collection experience, customer specific\nfacts and economic conditions. Account balances are charged off against the allowance after all means of collection have been exhausted\nand the potential for recovery is considered remote.\n\n \n\nInventories,\nnet\n\n \n\nInventories\nconsist of finished goods and are stated at the lower of cost or net realizable value. Cost is determined using the weighted average\ncost method. Net realizable value is defined as the estimated selling prices in the ordinary course of business, less reasonably predictable\ncosts of completion, disposal, and transportation. The Company reviews the carrying value of inventory for obsolescence or slow-moving\nitems periodically.\n\n \n\nAdvances\nto Suppliers\n\n \n\nThe\nCompany occasionally makes advance payments to suppliers, contractors, and service providers to secure future deliveries of goods or\ncompletion of services. These advances are recorded as assets on the balance sheet and are reclassified to the appropriate expense or\nasset account (such as inventory, property and equipment, or repairs and maintenance) when the related goods are received or the services\nare rendered. These advances may include, but are not limited to, payments for inventory goods to be sold, deposits for services, or\nprepayments for capital improvements.\n\n \n\nF-8\n\n \n\n \n\nThe\nCompany periodically reviews the recoverability of advances to suppliers and establishes allowances for potential losses when necessary.\n\n \n\nOther\nreceivables and current assets\n\n \n\nOther\nreceivables and current assets consist primarily of prepaid expenses, advances, and refundable security deposits. These items are recorded\nat their original transaction amounts and are not discounted as the impact of discounting is not material to the consolidated financial\nstatements. The Company evaluates the collectability of other receivables on a regular basis and establishes allowances for estimated\ncredit losses, if necessary, in accordance with ASC 326.\n\n \n\nImpairment\nof Other Assets\n\n \n\nThe\nCompany has adopted Accounting Standards Codification subtopic 340-10, Other Assets (“ASC 340-10”). ASC 340-10 requires that\nprepaid expenses, deferred costs, and other capitalized expenditures be reviewed for impairment whenever events or changes in circumstances\nindicate that the carrying amount of an asset may not be recoverable. The Company evaluates these assets for impairment periodically,\nor more frequently if events and circumstances warrant. Indicators of impairment may include contract cancellations, supplier bankruptcy,\nsignificant adverse changes in expected future benefits, or other factors reducing the asset’s recoverability.\n\n \n\nThe\nCompany assesses recoverability based on the expected future benefits associated with the asset. If it is determined that the carrying\nvalue is no longer recoverable, the asset is written down to its net realizable value or zero if no recovery is expected. Impairment\nlosses, if any, are recorded in the income statement as a charge to expense.\n\n \n\nImpairment\nloss on advances to suppliers was $nil and $27,000 for the years ended March 31, 2026, and 2025, respectively.\n\n \n\nProperty\nand Equipment\n\n \n\nProperty\nand equipment are carried at cost net of accumulated depreciation. Expenditures that improve the functionality of the related asset or\nextend the useful life are capitalized. When property and equipment is retired or otherwise disposed of, the related gain or loss is\nincluded in operating income. Leasehold improvements are depreciated on the straight-line method over the shorter of the remaining lease\nterm or estimated useful life of the asset.\n\n \n\nProperty\nand equipment are depreciated on a straight-line basis over the following periods:\n\n SCHEDULE OF PROPERTY AND EQUIPMENT DEPRECIATION \n\nLeasehold improvements \n 2 years \n\nOffice furniture and equipment \n 3 years \n\n \n\nIntangible\nassets\n\n \n\nIntangible\nassets are carried at cost, net of accumulated amortization. Expenditures that enhance the functionality or extend the useful life of\nthe intangible asset are capitalized. When intangible assets are retired or otherwise disposed of, the related gain or loss is included\nin operating income.\n\n \n\nIntangible\nassets with finite useful lives are amortized on a straight-line basis over their estimated useful lives. The Company reviews intangible\nassets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.\n\n \n\nIntangible\nassets are amortized on a straight-line basis over the following periods:\n\n SCHEDULE\nOF INTANGIBLE ASSETS ARE AMORTIZED ON A STRAIGHT - LINE BASIS \n\nPatent \n 10 years \n\n \n\nF-9\n\n \n\n \n\nImpairment\nof Long-Lived Assets\n\n \n\nThe\nCompany has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC\n360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever\nevents or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates its long-lived\nassets for impairment annually or more often if events and circumstances warrant. Events relating to recoverability may include significant\nunfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve breakeven operating results over an\nextended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should\nimpairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash\nflows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at\nthe lower of the carrying amount or the fair value less costs to sell.\n\n \n\nImpairment\nloss on property and equipment was $4,007 and $nil for the years ended March 31, 2026 and 2025, respectively.\n\n \n\nCustomer\nAdvances\n\n \n\nThe\nCompany records customer advances as liabilities when consideration is received in advance of the transfer of goods. These advances are\nrecognized as revenue when the performance obligations associated with the advance are satisfied. These advances relate to the advance\npayment for orders of goods placed by the customers.\n\n \n\nLeases\n\n \n\nThe\nCompany adopted FASB Accounting Standards Codification, Topic 842, Leases (“ASC 842”) using the modified retrospective approach,\nelecting the practical expedient that allows the Company not to restate its comparative periods prior to the adoption of the standard\non January 1, 2019.\n\n \n\nThe\nnew leasing standard requires recognition of leases on the balance sheets as right-of-use (“ROU”) assets and lease liabilities.\nROU assets represent the Company’s right to use underlying assets for the lease terms and lease liabilities represent the Company’s\nobligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized\nbased on the present value and future minimum lease payments over the lease term at commencement date. The Company’s future minimum\nbased payments used to determine the Company’s lease liabilities mainly include minimum based rent payments. As most of the Company’s\nleases do not provide an implicit rate, the Company uses its estimated incremental borrowing rate based on the information available\nat commencement date in determining the present value of lease payments. The Company does not recognize any leases with an initial term\nof 12 months or less on the balance sheets.\n\n \n\nOperating\nlease cost is recognized as a single lease cost on a straight-line basis over the lease term. Variable lease payments for common area\nmaintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances\non which the variable lease payments are based occur.\n\n \n\nRevenue\nRecognition\n\n \n\nRevenue\nis recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration\nwe expect to be entitled to in exchange for those goods or services. The Company determines revenue recognition by applying the following\nsteps: 1) identification of the contract, or contracts, with a customer; 2) identification of the performance obligations in the contract;\n3) determination of the transaction price; 4) allocation of the transaction price to the performance obligations in the contract; and\n5) recognition of revenue when, or as, we satisfy a performance obligation.\n\n \n\nF-10\n\n \n\n \n\n*Sales\nof goods*\n\n \n\nThe\nCompany generates revenue from the sale of health and beauty products, dietary supplements, and proprietary branded health foods. Goods\nare sold directly to consumers through the Company’s mobile application (“App”) and physical retail stores, as well\nas distributed wholesale to third-party e-commerce platforms and partners. In January 2026, the Company began transitioning its business\nmodel to become a primary product supplier of proprietary brands to enhance its control over the health and wellness supply chain.\n\n \n\nA formal contract is established when a customer places\nan order. The Company’s single performance obligation is the delivery of the ordered goods. The transaction price is generally fixed\nat the time of the order. Revenue is recognized at a point in time when the goods are delivered to (or physically purchased at) retail\nstores, drop-shipped, and accepted by the customer, as control transfers at that time.\n\n \n\nThe Company’s policy allows for product returns,\nwhich are treated as variable consideration. Provisions for estimated sales returns are assessed and adjusted at the end of each reporting\nperiod based on historical return rates and experience, which are generally immaterial. The Company records contract liabilities, such\nas customer advances, when payments are received prior to the delivery and acceptance of goods.\n\n \n\n*Offline\nphysical therapy services*\n\n \n\nThe\nCompany provides offline physical therapy and related health services through its physical retail stores. Customers may purchase\nthese services on a single-use (pay-on-demand) basis or through multi-session package deals that are valid for a one-year period. A formal contract is established upon payment.\n\n \n\nFor single-use services, the Company has a single\nperformance obligation to provide the therapy session. Revenue is recognized at a point in time when the service is rendered to the customer.\n\n \n\nFor\nmulti-session package deals, the Company has a stand-ready obligation to provide a specified number of therapy sessions over the one-year\n  validity period. While each treatment session represents a distinct performance obligation, the Company utilizes a stand-ready\nobligation approach for financial reporting purposes during the systems transition period, as precise customer-level session tracking\nis currently limited. Payments received in advance are initially recorded as contract liabilities (customer advances). These advance\npayments are non-refundable. Revenue is recognized over time as the services are utilized by the customer.\n\n \n\nDuring the systems transition\nperiod for the year ended March 31, 2026, precise customer-level usage tracking was limited. Consequently, management utilized a critical accounting estimate\nto determine the proportional performance of these obligations based on a sample of available historical usage records applied to cohorts\nof contracts grouped by payment date. Management applies a constraint to these estimates to ensure it is highly probable that a\nsignificant reversal of cumulative revenue recognized will not occur. Revenue is recognized ratably based on this constrained\nestimate, with any remaining unconstrained balance recognized when the rights legally expire at the end of the one-year period. Changes to these estimation methods could materially impact\nthe timing of revenue recognition.\n\n \n\n*Online\nplatform technical operation support and maintenance services*\n\n \n\nPrior\nto January 2026, the Company provided technical operation support and maintenance services for online platforms, ensuring platform functionality,\ncontinuous availability, and technical support for end-users.\n\n \n\nRevenue\nfrom these services was recognized ratably over each service period as the services were rendered, or upon completion of the service,\ndepending on the nature of the arrangement. Billing frequency varied (e.g., weekly, monthly, quarterly, or upon completion) as specified\nin the respective contracts. Service fees were determined based on contract terms and structured as fixed fees, milestone-based pricing,\nor as a percentage of gross transaction value (GTV) generated from the customer’s e-commerce platform. Each billing period or completed\nservice cycle represented a distinct performance obligation, with revenue recognized upon completion and invoicing. The major direct\ncost of providing these services was wages and salaries. In instances where payments were received in advance, they were recorded as\ncontract liabilities (deferred revenue) until the services were delivered.\n\n \n\nEffective\nJanuary 2026, the Company formally ceased providing these technical operation support and maintenance services. Because these services were supported by highly integrated, centralized\ncorporate resources that have been retained by the Company, the cessation of this service line does not qualify for presentation as a\ndiscontinued operation.\n\n \n\nPrincipal\nvs. Agent Consideration\n\n \n\nFor\neach revenue stream, the Company is a principal because it controls the specified goods or services before they are transferred to the\ncustomer. As a principal, the Company is primarily responsible for fulfilling the contractual obligations, has discretion in establishing\nthe price, and bears the risk of inventory or service provision until completion; therefore, revenue is recognized on a gross basis for\neach active revenue stream.\n\n \n\nF-11\n\n \n\n \n\nContract\nliabilities\n\n \n\nThe\nCompany records contract liabilities when payments are received from customers, or the Company has an unconditional right to receive\npayments, prior to the satisfaction of the underlying performance obligations. Contract liabilities primarily consist of customer advances\nand deferred revenue associated with the following:\n\n \n\n●Delivery\nof goods: Customer advances received prior to the delivery and acceptance of goods. These\nadvances are recognized as revenue upon delivery and acceptance of the goods by customers.\n\n●Multi-Session\npackage deals: Payments received in advance of services rendered. These advances are initially\nrecorded as contract liabilities and recognized as revenue as the individual sessions are\ndelivered to the customer, or upon expiration of the one-year term.\n\n●Online\nplatform support services: Payments received in advance for online platform technical operation\nsupport and maintenance services. These amounts are recorded as deferred revenue and recognized\nas revenue over the period the support services are delivered.\n\n \n\nContract\nliability balances comprised of the following:\n\nSCHEDULE OF CONTRACT\nLIABILITY BALANCES  \n\n  \n\n**March 31,**\n\n**2026**\n  \nMarch 31,\n2025 \n\nOpening balance \n$8,475  \n$4,345 \n\nPayments received in advance \n 571,997  \n 4,130 \n\nRevenues recognized \n (482,867) \n - \n\nEffect of exchange rate changes \n -  \n - \n\nEnding balance \n$97,605  \n$8,475 \n\n \n\nThe\nCompany recognized revenue of $482,867 and $nil for the years ended March 31, 2026 and 2025, respectively, that was included in the contract\nliability balance at the beginning of each respective period.\n\n \n\nSelling,\nGeneral and Administrative Expenses\n\n \n\nSelling,\ngeneral, and administrative expenses primarily consist of costs related to sales and marketing activities, administrative functions,\nand certain start-up costs.\n\n \n\nSelling\nexpenses include, but are not limited to, sales commissions, advertising costs, shipping and handling expenses, and costs associated\nwith trade shows and promotional events. General and administrative expenses encompass salaries and benefits of employees not directly\ninvolved in production, rent, utilities, office supplies, legal and professional fees, other overhead costs, and certain start-up costs.\n\n \n\nStart-up\ncosts represent expenses associated with the establishment of new operations, including activities such as market research, product development,\nand initial marketing efforts.\n\n \n\nThe\nCompany recognizes these expenses as incurred.\n\n \n\nDefined\nContribution Plans\n\n \n\nThe\nCompany contributes to various government-mandated employee benefit plans in the People’s Republic of China, including pension,\nmedical, unemployment, and housing provident funds. These contributions are made in accordance with local laws and regulations and are\nexpensed as incurred. The Company’s obligations under these plans are limited to the amounts required to be contributed. For the\nyears ended March 31, 2026 and 2025, the Company contributed approximately $68,666 and $165,510, respectively.\n\n \n\nIncome\nTaxes\n\n \n\nThe\nCompany records income tax expense using the asset-and-liability method of accounting for deferred income taxes. Under this method, deferred\ntaxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their\nfinancial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the\ndifferences are expected to affect taxable income. Deferred tax assets are reduced by a valuation allowance if, based on available evidence,\nit is more likely than not that the deferred tax assets will not be realized.\n\n \n\nF-12\n\n \n\n \n\nWhen\ntax returns are filed, it is likely some positions taken would be sustained upon examination by the taxing authorities, while others\nare subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The\nbenefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management\nbelieves it is more-likely-than-not the position will be sustained upon examination, including the resolution of appeals or litigation\nprocesses, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not\nrecognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement\nwith the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount described\nabove is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest\nand penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is\nclassified as interest expense and penalties are classified in general and administrative expenses in the statements of operations.\n\n \n\nEarnings\nPer Share\n\n \n\nThe\nCompany computes basic and diluted earnings per share amounts in accordance with ASC Topic 260, Earnings per Share. Basic earnings per\nshare is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding\nduring the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments\nto issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings\nof the Company.\n\n \n\nAs\nof March 31, 2026 and 2025, the Company does not have any potentially dilutive instrument.\n\n \n\nContingencies\n\n \n\nCertain\nconditions may exist as of the date the financial statements are issued, which could result in a loss to the Company which will be resolved\nwhen one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such\nassessment inherently involves judgment. In assessing loss contingencies arising from legal proceedings pending against the Company or\nunasserted claims that may rise from such proceedings, the Company’s management evaluates the perceived merits of any legal proceedings\nor unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.\n\n \n\nIf\nthe assessment of a contingency indicates it is probable a material loss will be incurred and the amount of the loss can be reasonably\nestimated, then the estimated loss is accrued in the Company’s financial statements. If the assessment indicates a material loss\ncontingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability,\ntogether with an estimate of the range of possible loss if determinable and material would be disclosed.\n\n \n\nFair\nValue Measurements\n\n \n\nFair\nvalue accounting establishes a framework for measuring fair value and expands disclosure about fair value measurements. Fair value, which\nis defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market\nparticipants at the measurement date. This framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques\nused to measure fair value into three levels as follows:\n\n \n\n \n●\nLevel\n1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.\n\n \n\nF-13\n\n \n\n \n\n \n●\nLevel\n2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that\nare observable for the assets or liabilities, either directly or indirectly, for substantially the full term of the financial instruments.\n\n \n \n \n\n \n●\nLevel\n3 inputs to the valuation methodology are unobservable and significant to the fair value.\n\n \n\nThe\nCompany’s financial instruments consisted of cash, accounts receivables, accounts payable, contract liabilities and loan from shareholders.\nThe estimated fair value of those balances approximates the carrying amount due to the short maturity of these instruments.\n\n \n\nCredit\nLosses on Financial Instruments\n\n \n\nThe\nCompany recognizes credit losses on financial instruments in accordance with Accounting Standards Codification (ASC) Topic 326, Financial\nInstruments – Credit Losses. The Company uses the Current Expected Credit Losses (CECL) model to estimate credit losses on financial\nassets measured at amortized cost, as well as certain off-balance sheet credit exposures.\n\n \n\nUnder\nthe CECL model, the estimation of credit losses involves significant judgment and estimation uncertainty. Management exercises its judgment\nbased on historical loss experience, current economic conditions, and reasonable and supportable forecasts. Changes in these factors\ncould have a material impact on the estimated credit losses.\n\n \n\nSegment Reporting\n\n \n\nThe Company follows the management approach for segment\nreporting in accordance with ASC 280, *Segment Reporting*. This approach is based on the way management organizes segments within\nthe Company for making operating decisions and assessing performance. The Company’s Chief Executive Officer has been identified as the\nChief Operating Decision Maker (“CODM”). As the Company’s underlying operations and cost structures are highly integrated, the\nCODM evaluates performance and allocates resources based on consolidated financial information. Accordingly, the Company has determined\nthat it operates as a single reportable segment. Further details regarding the Company’s segment reporting are provided in Note\n13.\n\n \n\nRecent\nAccounting Pronouncements\n\n \n\nAccounting\nStandards Update (“ASU”) 2025-06, Intangibles — Goodwill and Other — Internal-Use Software (Subtopic 350-40):\nTargeted Improvements to the Accounting for Internal-Use Software modernizes the accounting for internal-use software by removing the\nrequirement to identify discrete project development stages (such as the preliminary and application-development stages) and instead\nfocuses on whether (1) management has authorized and committed to funding the project, (2) it is probable the project will be completed\nand the software will be used to perform its intended function, and (3) the entity has considered whether significant uncertainty exists\nin the development activities. The amendments are effective for fiscal years beginning after December 15, 2027, and for interim periods\nwithin those fiscal years. Early adoption is permitted. Entities may apply the amendments prospectively, retrospectively, or using a\nmodified-prospective approach. The Company is currently evaluating the impact of ASU 2025-06 on its consolidated financial statements\nand related disclosures. The adoption is expected to primarily affect the timing of capitalizing certain software-development costs and\nmay result in modifications to internal controls over capitalization judgments and related disclosures.\n\n \n\nASU\n2025-05, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets\nintroduces a practical expedient for measuring expected credit losses on current accounts receivable and current contract assets arising\nfrom contracts with customers under Topic 606. Under the expedient, entities may assume that conditions existing at the balance sheet\ndate will remain unchanged over the asset’s remaining life when estimating expected credit losses. In addition, entities other\nthan public business entities may elect, as an accounting policy, to consider subsequent cash collections that occur after the balance\nsheet date but before issuance of the financial statements when estimating expected credit losses. The amendments are effective for fiscal\nyears beginning after December 15, 2025, and for interim periods within those fiscal years. Early adoption is permitted, and the guidance\nis to be applied prospectively. The Company is currently evaluating the impact of ASU 2025-05 and does not expect the adoption to have\na material impact on its consolidated financial statements. The Company expects to apply the practical expedient for qualifying current\nreceivables and contract assets upon adoption.\n\n \n\nASU\n2025-04, Compensation—Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Customer Share-Based\nPayment Awards, clarifies how entities account for share-based consideration payable to a customer. The ASU requires customer awards\nwith vesting conditions tied to purchases to be treated as performance conditions, eliminates the forfeiture policy election, and states\nthat the variable consideration constraint under ASC 606 does not apply to these awards. The standard is effective for annual periods\nbeginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of this guidance on\nits financial statements.\n\n \n\nF-14\n\n \n\n \n\nASU\n2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Accounting Acquirer in a Business Combination Involving a Variable\nInterest Entity, clarifies that when a business that is a VIE is acquired primarily with equity interests, the determination of the accounting\nacquirer should follow ASC 805 rather than defaulting to the primary beneficiary under ASC 810. The standard is effective for fiscal\nyears beginning after December 15, 2026, including interim periods within those fiscal years. Early adoption is permitted. The Company\ndoes not expect a material impact upon adoption.\n\n \n\nASU\n2025-02, Liabilities (Topic 405): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 122, removes the guidance\npreviously provided under SAB 121 and codified in ASC 405-S99. The amendment reflects the SEC’s rescission of SAB 121 and clarifies\nthat custodians of crypto-assets should assess loss contingencies under ASC 450-20. This update is effective retrospectively for public\nbusiness entities for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this standard to\nhave a material impact on its financial statements.\n\n \n\nASU\n2025-01, Presentation of Financial Statements (Topic 220): Clarifying the Effective Date of Disaggregation of Income Statement Expenses,\nconfirms the effective date of ASU 2024-03 for public business entities. The guidance requires disaggregated expense information in the\nincome statement and is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning\nafter that date. Early adoption is permitted. The Company is currently evaluating the impact of this standard.\n\n \n\nManagement\ndoes not believe that other recently issued but not yet adopted accounting pronouncements will have a material impact on the Company’s\nfinancial position, results of operations, or cash flows.\n\n \n\n**NOTE\n3 – GOING CONCERN**\n\n \n\nThe\nCompany’s financial statements have been prepared on a going concern basis, which contemplates the realization of assets and settlement\nof liabilities and commitments in the normal course of business. The Company has incurred net loss of $837,646 for the period ended March\n31, 2026, had an accumulated deficit of $2,247,358, and working capital deficit of $459,038. These factors, among others, raise substantial\ndoubt about the Company’s ability to continue as a going concern.\n\n \n\nManagement’s\nplan to alleviate the substantial doubt about the Company’s ability to continue as a going concern include attempting to improve\nits business profitability, its ability to generate sufficient cash flow from its operations to meet its operating needs on a timely\nbasis, obtain additional working capital funds from the majority shareholder and President of the Company to eliminate inefficiencies\nin order to meet its anticipated cash requirements. However, there can be no assurance that these plans and arrangements will be sufficient\nto fund the Company’s ongoing capital expenditures and other requirements.\n\n \n\nThe\nfinancial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts\nand classification of liabilities that might be necessary in the event that the Company cannot continue as a going concern.\n\n \n\n**NOTE\n4 – ACCOUNTS RECEIVABLE, NET**\n\n \n\nAccounts\nreceivable, net comprised of the following:\n\nSCHEDULE\nOF ACCOUNTS RECEIVABLES \n\n  \n\n**March 31,**\n\n**2026**\n  \nMarch 31,\n2025 \n\nAccounts receivable \n$30,000  \n$85,788 \n\nLess: Allowance for credit loss \n -  \n - \n\nTotal, net \n$30,000  \n$85,788 \n\n \n\nThere\nwas no allowance for credit loss expenses for the years ended March 31, 2026 and 2025, respectively.\n\n \n\nF-15\n\n \n\n \n\n**NOTE\n5 – INVENTORIES, NET**\n\n \n\nInventories,\nnet comprised of the following:\n\nSCHEDULE\nOF INVENTORIES, NET \n\n  \n\n**March 31,**\n\n**2026**\n  \nMarch 31,\n2025 \n\nFinished goods \n$221,476  \n$- \n\nFinished goods in transit \n 7,610  \n - \n\nLess: Obsolete/write-down inventory \n (10,050) \n - \n\nTotal, net \n$219,036  \n$- \n\n \n\nWrite-downs\nof inventories were $10,050\nand $nil\nfor the years ended March 31, 2026 and 2025, respectively.\n\n** **\n\n**NOTE\n6 – OTHER RECEIVABLES AND CURRENT ASSETS**\n\n \n\nOther\nreceivables and current assets, net comprised of the following:\n\nSCHEDULE\nOF OTHER RECEIVABLES AND CURRENT ASSETS \n\n  \n\n**March 31,**\n\n**2026**\n  \nMarch 31,\n2025 \n\nOther receivables and prepayments \n$170,131  \n$165,740 \n\nSecurity deposits \n 57,995  \n 56,315 \n\nTaxes recoverable \n 1,811  \n   \n\nLess: Allowance for credit loss \n -  \n - \n\nTotal, net \n$229,937  \n$222,055 \n\n \n\nThere\nwas no allowance for credit loss expenses for the years ended March 31, 2026 and 2025, respectively.\n\n \n\n**NOTE\n7 – PROPERTY AND EQUIPMENT, NET**\n\n \n\nProperty\nand equipment, net comprised of the following:\n\nSCHEDULE OF PROPERTY AND EQUIPMENT \n\n  \n\n**March 31,**\n\n**2026**\n  \nMarch 31,\n2025 \n\nAt Cost: \n    \n   \n\nLeasehold improvements \n$375,463  \n$248,614 \n\nOffice furniture and equipment \n 67,349  \n 22,716 \n\nProperty plant and equipment , gross \n 67,349  \n 22,716 \n\nTotal cost \n 442,812  \n 271,330 \n\nLess: Accumulated depreciation \n (294,597) \n (150,561)\n\nTotal, net \n$148,215  \n$120,769 \n\n \n\nDepreciation\nexpenses were $133,383 and $65,120 for the years ended March 31, 2026 and 2025, respectively.\n\n \n\nImpairment\nlosses were $4,007 and $nil for the years ended March 31, 2026 and 2025, respectively.\n\n \n\nThe\nCompany did not dispose of any fixed assets for the years ended March 31, 2026 and 2025, respectively. Accordingly, no gain or loss on\ndisposal of fixed assets was recognized.\n\n \n\nF-16\n\n \n\n \n\n**NOTE\n8 – INTANGIBLE ASSET, NET**\n\n \n\nIntangible\nasset, net comprised of the following:\n\nSCHEDULE\nOF INTANGIBLE ASSET \n\n  \n\n**March 31,**\n\n**2026**\n  \n\n**March 31,**\n\n**2025**\n \n\nAt Cost: \n    \n   \n\nPatent \n$14,497  \n$13,781 \n\nTotal cost \n 14,497  \n 13,781 \n\nLess: Accumulated amortization \n (1,691) \n (230)\n\nTotal, net \n$12,806  \n$13,551 \n\n \n\nAmortization\nexpenses were $1,409 and $230 for the years ended March 31, 2026 and 2025, respectively.\n\n \n\nThe\namortization expenses for the succeeding five years as follows:\n\nSCHEDULE\nOF AMORTIZATION EXPENSES FOR THE SUCCEEDING YEARS \n\nFor the year ending March 31, \n  \n\n2027 \n$1,408 \n\n2028 \n 1,408 \n\n2029 \n 1,408 \n\n2030 \n 1,408 \n\n2031 \n 1,408 \n\nThereafter \n 5,766 \n\nTotal \n$12,806 \n\n \n\n**NOTE\n9 – LOANS PAYABLE AND NOTES PAYABLE**\n\n \n\nPromissory\nNotes and Related Party Assignments\n\n \n\nOn\nDecember 31, 2024, the Company entered into promissory note agreements amending the terms of certain existing loan arrangements with\na third-party outstanding balances of CNY 3,931,167\n(approximately $538,568)\nand CNY 2,096,172\n(approximately $287,174),\nincluding an extension of the maturity date to December\n31, 2029. As a result of these amendments, the outstanding balances were reclassified from “Loans Payable” to\n“Notes Payable.” These notes were unsecured, non-interest-bearing, and had a stated maturity date of December 31,\n2029.\n\n \n\nOn\nMarch 24, 2025, the Company borrowed CNY 2,800,000 (approximately $386,042) from another unrelated third party pursuant to a loan agreement.\nThe loan was unsecured, non-interest-bearing, and had a stated maturity date of December 9, 2027.\n\n \n\nOn\nMarch 31, 2025, the Company entered into a tripartite debt assignment agreement (the “Tripartite Debt Assignment\nAgreement”) with a related party (Mr. Barry Wan), and the unrelated third-party lender mentioned above, pursuant to which the CNY 2,096,172\nnote, the CNY 2,800,000\nloan, and the CNY 3,931,167\nnote were assigned to the related party under the same terms and conditions.\n\n \n\nDebt\nAssignment and Conversion\n\n \n\nOn\nNovember 25, 2025, the Company cancelled the Tripartite Debt Assignment Agreement, and entered into new assignment and amendment\nagreements specifically for the CNY 2,096,172\nand CNY 3,931,167\npromissory notes (the “November Debt Assignment Agreements”). These notes were now assigned to third-party assignees and\nincluded a provision for the automatic conversion of the outstanding principal amounts into shares of the Company’s Class A\ncommon stock at a fixed conversion price.\n\n \n\nImmediately\nupon the effectiveness of the amendments, the total principal of $1,284,102\nfrom the promissory notes (one consolidated note\nconsisting of the CNY 2,096,172\n(approximately $538,568)\nand CNY 3,931,167\n(approximately $287,174)\nbalance, and a second consolidated note of $428,790\nowing to Mr. Wan, the President of the Company, and the $29,571\nowing to New Lite), as elaborated in Note 10, were automatically converted into 4,280,340\nshares of the Company’s Class A common stock at $0.30\nper share.\n\n \n\nThe\nCNY 2,800,000 loan\nwas not included in the November Debt Assignment Agreements. Upon the cancellation of the Tripartite Debt Assignment Agreement, this\nloan remained outstanding under its original terms as an obligation to an unrelated third party. The loan is unsecured,\nnon-interest-bearing, with a maturity date of December\n9, 2027. As of March 31, 2026 and\n2025, the Company has outstanding loans payable to the unrelated third party in the amount of $405,915 and\n$nil,\nrespectively.\n\n \n\nF-17\n\n \n\n \n\n**NOTE\n10 – RELATED PARTY TRANSACTIONS**\n\n \n\nDue\nto related parties\n\n \n\nDue\nto related parties comprised of the following:\n\nSCHEDULE\nOF DUE TO RELATED PARTIES \n\n  \n\n**March 31,**\n\n**2026**\n  \nMarch 31,\n2025 \n\nBarry Wan (“Mr. Wan”) \n$980,000  \n$520,000 \n\nTotal \n$980,000  \n$520,000 \n\n \n\nAmounts\ndue to related parties were unsecured, non-interest-bearing, and due on demand.\n\n \n\nPromissory\nNotes Payable and Loans Payable – Related Parties\n\n \n\nThe\nCompany had long-term notes and loans payable-related parties (Mr. Wan, the Company’s President)\nof $nil and $1,674,801 as of March 31, 2026 and 2025, respectively. These arrangements were unsecured and non-interest-bearing, with $385,850 repayable on December 9, 2027, and the remaining $1,288,951\nrepayable on December 31, 2029.\n\n \n\nAdvances\nfrom Mr. Wan\n\n \n\nDuring\nthe years ended March 31, 2026, the Company received advances from Mr. Wan, the Company’s President, for working capital purposes.\nThe outstanding amounts due to Mr. Wan were $980,000 and $520,000 as of March 31, 2026 and 2025, respectively. The advances were unsecured,\nnon-interest-bearing, and due on demand.\n\n \n\nOn\nDecember 31, 2024, the Company formalized a promissory note agreement with Mr. Wan in the principal amount of $428,790, with a stated\nmaturity date of December 31, 2029. As described in Note 9, this promissory note was subsequently assigned and converted into equity.\n\n \n\nDebt\nAssignment to Mr. Wan\n\n \n\nOn\nMarch 31, 2025, the Company entered into a Tripartite Debt Assignment Agreement (“TDAA”) with Mr. Barry Wan (a related\nparty) and the unrelated third-party original lender, pursuant to which the CNY 2,096,172\n($288,860)\nnote, the CNY 2,800,000\n($385,850)\nloan, and the CNY 3,931,167\n($541,730)\nnote; were legally assigned to Mr. Wan. Following the assignment, Mr. Wan became the holder of the obligations under the same terms\nand conditions. The outstanding long-term notes and loans\npayable-related party was $nil\nand $1,674,801\nas of March 31, 2026 and 2025, respectively.\n\n \n\nSubsequently,\non November 25, 2025, the Company cancelled the TDAA and entered into new assignment and amendment agreements with respect to the\noutstanding promissory notes (under “November Debt Assignment Agreements”), pursuant to which the notes were assigned to\nthird-party assignees and amended to provide for the automatic conversion of the outstanding principal amounts into shares of the\nCompany’s Class A common stock at a fixed conversion price. Immediately upon the effectiveness of the amendments, the\noutstanding promissory notes were automatically converted into equity. The CNY 2,800,000\n(approximately $385,850) loan was not included in the November Debt Assignment Agreements.\n\n \n\nAdvances\nfrom Tairan Baohe Insurance Sales Co., Ltd. (“Tairan”)\n\n \n\nDuring\nthe year ended March 31, 2025, the Company borrowed funds from Tairan Baohe Insurance Sales Co., Ltd. (“Tairan”), an entity\nin which Mr. Wan’s spouse is a shareholder, for working capital purposes. The loan was unsecured, non-interest-bearing, and due\non demand. On December 31, 2024, the Company formalized a promissory note agreement in the principal amount of CNY 2,800,000 (approximately\n$383,598), with a stated maturity date of December 31, 2029.\n\n \n\nOn\nMarch 24, 2025, the Company repaid the full outstanding balance to Tairan. As a result, there were no amounts due to Tairan since then.\n\n \n\nF-18\n\n \n\n \n\nAdvances\nfrom New Lite Ventures LLC (“New Lite”)\n\n \n\nDuring\nthe year ended March 31, 2025, the Company borrowed funds from New Lite Ventures LLC (“New Lite”), an entity controlled by\nMr. Wan, for working capital purposes. The advances were unsecured, non-interest-bearing, and due on demand.\n\n \n\nOn\nDecember 31, 2024, the Company formalized a promissory note agreement with New Lite in the principal amount of $29,571, with a stated\nmaturity date of December 31, 2029. On November 25, 2025, this promissory\nnote was assigned to third-party assignees and converted into the Company’s Class A common stock.\n\n \n\n**NOTE\n11 – INCOME TAX**\n\n \n\nThe\nCompany has not recognized an income tax benefit for its operating losses generated based on uncertainties concerning its ability to\ngenerate taxable income in future periods. The tax benefit for the period presented is offset by a valuation allowance established against\ndeferred tax assets arising from the net operating losses, the realization of which could not be considered more likely than not. In\nfuture periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts\nto be more likely than not.\n\n \n\n*United\nStates*\n\n \n\nNet\noperation losses (“NOLs”) can carry forward indefinitely up to offset 80% of taxable income after CARES Act effect on\nDecember 31, 2017. As of March 31, 2026, deferred tax assets resulted from NOLs of approximately $302,000,\nrespectively. The deferred tax asset has been fully reserved by a valuation allowance as the Company believes it is more likely than\nnot that it will not realize the benefits.\n\n \n\n*Hong\nKong*\n\n \n\nCompanies\nincorporated in Hong Kong are subject to Hong Kong Profits Tax on the taxable income as reported in its statutory financial statements\nadjusted in accordance with relevant Hong Kong tax laws. The applicable tax rate is 16.5% on its taxable income generated from operations\nin Hong Kong. The Company did not make any provisions for Hong Kong profit tax as there were no assessable profits derived from or earned\nin Hong Kong since inception. Additionally, payments of dividends by the subsidiary incorporated in Hong Kong to the Company are not\nsubject to any Hong Kong withholding tax.\n\n \n\n*PRC*\n\n \n\nEffective\non January 1, 2008, the PRC Enterprise Income Tax Law, EIT Law, and Implementing Rules impose a unified enterprise income tax rate of\n25% on all domestic-invested enterprises and foreign investment enterprises in PRC, unless they qualify under certain limited exceptions.\nAs such, starting from January 1, 2008, the Company’s subsidiaries in PRC are subject to an enterprise income tax rate of 25%.\nNOLs can typically carried forward for a certain number of years (usually five years) to offset against future taxable income. As of\nMarch 31, 2026, the Company’s PRC operations had net operating losses which resulted in deferred tax assets of approximately $212,000.\nThe deferred tax asset has been fully reserved for valuation allowance as the Company believes it is more likely than not that it will not realize\nthe benefits.\n\n \n\nIncome\nTaxes Paid\n\n \n\nFor\nthe years ended March 31, 2026, the Company paid income taxes of $16,635 in China and $25 in United States; and did not pay any income\ntaxes domestically or in foreign jurisdictions for the years ended March 31, 2025.\n\n \n\nThe\nfollowing table summarizes the taxable income (loss) before income taxes by jurisdiction:\n\n SCHEDULE\nOF TAXABLE INCOME (LOSS) BEFORE INCOME TAXES\n\n  \n2026  \n2025 \n\n  \n\n**Years ended**\n\n**March 31,**\n \n\n  \n2026  \n2025 \n\nUnited States \n$(650,153) \n$(322,344)\n\nHong Kong \n -  \n - \n\nChina \n (170,833) \n (398,065)\n\nTotal \n$(820,986) \n$(720,409)\n\n \n\nF-19\n\n \n\n \n\nThe\nfollowing table summarizes a reconciliation of income tax expense for operations, calculated at the statutory income tax rate to total\nincome tax expense (benefit):\n\n SCHEDULE\nOF RECONCILIATION OF INCOME TAX EXPENSE FOR OPERATIONS\n\n  \n2026  \n2025 \n\n  \n\n**Years ended**\n\n**March 31,**\n \n\n  \n2026  \n2025 \n\nLoss before income taxes \n$(820,986) \n$(720,409)\n\nU.S. federal tax benefits (21%) \n (136,532) \n (67,692)\n\nState tax benefit, net of federal benefits \n (38,522) \n (19,099)\n\nPRC tax expenses (benefits) (25%) \n (42,708) \n (99,516)\n\nHong Kong tax benefits (16.5%) \n -  \n - \n\nIncome tax benefits at statutory rate \n (217,762) \n (186,307)\n\nForeign tax rate differential \n -  \n - \n\nChange in valuation allowance \n 234,422  \n 186,307 \n\nOther \n -  \n - \n\nProvision for income taxes expenses \n$16,660  \n$- \n\nEffective tax rate \n (2.03)% \n 0%\n\n \n\n**NOTE\n12 – SHAREHOLDERS’ EQUITY**\n\n \n\nThe\nCompany is authorized to issued 1,200,000,000 shares of Class A common stock, 1,200,000,000 Class B common stock, 1,200,000,000 Class\nC common stock, 1,200,000,000 Class D common stock, and 1,200,000,000 Class E common stock; all with a par value of $0.00001 per share.\n\n \n\nAs\nof March 31, 2026, the Company had 34,275,340 shares of Class A common stock issued and outstanding, and no shares of Class B, Class\nC, Class D, or Class E common stock were issued or outstanding.\n\n \n\nOn\nJune 6, 2024, the Company amended its article with New York State to increase the authorized shares of common stock of the Company from\nthirty million (30,000,000) shares of common stock, par value $0.001 per share, to six billion (6,000,000,000) shares of common stock,\npar value $0.00001 per share (the “Authorized Capital Increase”). Upon the effectiveness of the authorized shares increase,\nthe shares of common stock will be categorized as follows: 1,200,000,000 Class A shares, 1,200,000,000 Class B shares, 1,200,000,000\nClass C shares, 1,200,000,000 Class D shares, and 1,200,000,000 Class E shares.\n\n \n\nDuring\nthe years ended March 31, 2026, the Company issued 4,280,340 shares of Class A common stock upon the automatic conversion of promissory\nnotes in accordance with the assignment and amendment agreements described in Note 9.\n\n \n\nF-20\n\n \n\n \n\n**NOTE\n13 – SEGMENT REPORTING**\n\n** **\n\nSegment\nIdentification and Chief Operating Decision Maker\n\n \n\nThe\nCompany operates and is managed as a 1single\nreportable segment. The Company has identified its Chief Executive Officer as the Chief Operating Decision Maker\n(“CODM”). The CODM evaluates performance and allocates resources based on the Company’s consolidated financial\ninformation, specifically utilizing consolidated net loss to make operating decisions. While the Company’s revenue streams\nacross health and beauty products, technical support, and physical therapy which are distinct, the underlying operations, shared\nresources, and cost structures utilized to generate these revenues are highly integrated across the entire Company. Consequently,\nthe CODM does not evaluate performance or allocate resources based on discrete financial information for the individual product or\nservice lines.\n\n \n\nIn\nevaluating the Company’s single operating segment’s performance, the CODM is regularly provided with certain significant\nconsolidated expenses. These primarily consist of cost of revenues, selling and marketing expenses, and general and administrative expenses.\nThese costs represent significant segment expenses and are reported directly on the consolidated statements of operations. Other segment\nitems include interest income, other income, and income tax expense.\n\n** **\n\nDisaggregation\nof revenues\n\n \n\nThe\nCompany disaggregates its revenue by major revenue streams, as the Company believes this disaggregation best depicts how the nature,\namount, timing and uncertainty of the revenue and cash flows are affected by economic factors.\n\n SCHEDULE OF DISAGGREGATION OF REVENUES\n\n  \n2026  \n2025 \n\n  \n\n**Years ended**\n\n**March 31,**\n \n\n  \n2026  \n2025 \n\nSales of goods (Health and beauty products) \n$180,950  \n$- \n\nTechnical operation support and maintenance services \n 711,607  \n 817,898 \n\nOffline physical therapy services \n 141,828  \n - \n\nTotal \n$1,034,385  \n$817,898 \n\n \n\nGeographic\nInformation\n\n \n\nThe\nCompany’s revenues from external customers are attributed to geographic areas based on the location of the customer. Geographic\ninformation regarding the Company’s long-lived assets, which specifically consists primarily of property, plant, and equipment,\nand right-of-use assets, is based on physical location.\n\n \n\nRevenue\ndisaggregated by geographic area based on the location of the customers is as follows:\n\n SCHEDULE\nOF REVENUE DISAGGREGATED BY GEOGRAPHIC AREA\n\n  \n2026  \n2025 \n\n  \n\n**Years ended**\n\n**March 31,**\n \n\n  \n2026  \n2025 \n\nUnited States \n$322,778  \n$- \n\nChina \n 711,607  \n 817,898 \n\nTotal \n$1,034,385  \n$817,898 \n\n \n\nLong-lived\nassets by geographic area based on physical location is as follows:\n\n** **SCHEDULE\nOF LONG-LIVED ASSETS BY GEOGRAPHIC AREA\n\n  \n\n**March 31,**\n\n**2026**\n  \nMarch 31,\n2025 \n\nUnited States \n$492,831  \n$423,993 \n\nChina \n 3,066  \n 341,291 \n\nTotal, net \n$495,897  \n$765,284 \n\n** **\n\n****\n\nF-21\n\n \n\n** **\n\n**NOTE\n14 – LEASES**\n\n \n\nThe\nCompany has various operating leases for its office space and retail space.\n\n \n\nOperating\nlease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the\nlease term. The discount rate used to calculate the present value is incremental borrowing rate or, if available, the rate implicit in\nthe lease. The Company determines the incremental borrowing rate for each leases based primarily on its lease term.\n\n \n\nCertain\nlease agreements may include renewal options that are exercisable at the Company’s discretion. The Company includes renewal periods\nin the lease term when it is reasonably certain that the renewal option will be exercised. For leases where the renewal is not reasonably\ncertain, the extension options are excluded from the measurement of lease liabilities and right-of-use assets. The lease term used reflects\nonly the non-cancellable period and any renewal options that the Company is reasonably certain to exercise.\n\n \n\nOperating\nlease expenses were $412,352 and $330,671 for the years ended March 31, 2026 and 2025, respectively. The Company did not have short-term\nleases or subleases for the years ended March 31, 2026 and 2025. Lease payments are fixed and increase annually according to the stated\nterms in the lease agreements. The Company does not have any variable lease payments.\n\n \n\nThe\ncomponents of lease expense and supplemental cash flow information related to leases for the period are as follows:\n\n SCHEDULE OF LEASE EXPENSES AND SUPPLEMENTAL CASH FLOW INFORMATION\n\n  \n\n**Years ended**\n\n**March 31,**\n \n\n  \n2026  \n2025 \n\nLease cost \n    \n   \n\nOperating lease cost \n$412,352  \n$330,671 \n\n  \n    \n   \n\nOther Information \n    \n   \n\nCash paid for amounts included in the measurement of lease liabilities \n$72,360  \n$338,389 \n\nWeighted average remaining lease term – operating leases\n(in years) \n 5.59  \n 6.57 \n\nAverage discount rate – operating lease \n 7.00% \n 7.00%\n\n \n\nThe\nsupplemental balance sheet information related to leases is as follows:\n\n SCHEDULE OF SUPPLEMENTAL BALANCE SHEET INFORMATION RELATED TO LEASE\n\n  \n\n**March 31,**\n\n**2026**\n  \n\n**March 31,**\n\n**2025**\n \n\nOperating leases \n    \n   \n\nRight-of-use assets \n$347,682  \n$644,515 \n\nOperating lease liabilities \n$370,793  \n$412,790 \n\n \n\nThe\nundiscounted future minimum lease payment schedule as follows:\n\n SCHEDULE OF UNDISCOUNTED FUTURE MINIMUM LEASE PAYMENTS\n\nFor the year ending March 31, \n  \n\n2027 \n$75,087 \n\n2028 \n 77,340 \n\n2029 \n 79,660 \n\n2030 \n 82,050 \n\n2031 \n 84,511 \n\nThereafter \n 50,150 \n\nTotal undiscounted lease payments \n 448,798 \n\nLess: interest \n (78,005)\n\nTotal lease liabilities \n$370,793 \n\n \n\n****\n\nF-22\n\n \n\n** **\n\n**NOTE\n15 – RISKS, COMMITMENTS AND CONTINGENCIES**\n\n \n\n*Litigations\nand claims*\n\n \n\nTo\nthe best of the Company’s knowledge and based on information available as of March 31, 2026, the Company is not involved in any\nmaterial claims or legal actions arising from the ordinary course of business. However, the Company is exposed to various risks and uncertainties\nthat could potentially result in litigation or claims in the future. The Company continuously evaluates these contingencies and will\nadjust its disclosures as necessary.\n\n \n\n*Concentration\nRisks*\n\n \n\nFor\nthe years ended March 31, 2025, the Company derived 100% of its revenue from a single customer. Additionally, the Company has only one\nsupplier for its primary service.\n\n \n\nFor\nthe years ended March 31, 2026, the Company derived 50.6%   and 18.4%   of its revenue from two customers. Additionally,\nthe Company purchased 74.1% from one supplier   for its purchased goods.\n\n \n\nThe\nCompany is economically dependent on limited customer and supplier, and the loss of its relationship with the customer and supplier could\nhave a material adverse effect on its financial condition, results of operations, and cash flows.\n\n \n\n**NOTE\n16 – SUBSEQUENT EVENTS** \n\n \n\nThe\nCompany evaluated all events and transactions that occurred after March 31, 2026 through the date the financial statements were issued.\nDuring this period, the Company did not identify any material recognized subsequent events that require adjustment to the accompanying\nfinancial statements.\n\n \n\nOn April 1, 2026, the Company entered into a 36-month\noperating lease agreement for office space in Hangzhou, PRC, which commenced on April 1, 2026. The total undiscounted base rent commitment\nover the lease term is approximately RMB 3.87 million, which includes an initial upfront payment of approximately RMB 2.46 million. In\naccordance with ASC 842, the Company expects to record a material operating lease right-of-use (“ROU”) asset and corresponding\nlease liability on its consolidated balance sheets.\n\n \n\nF-23"}